Literature DB >> 7067499

Presentation of sarcoidosis and outcome of pulmonary changes.

F K Rømer.   

Abstract

Entities:  

Mesh:

Year:  1982        PMID: 7067499

Source DB:  PubMed          Journal:  Dan Med Bull        ISSN: 0907-8916


× No keyword cloud information.
  8 in total

1.  Internal medicine-important advances in clinical medicine: pulmonary sarcoidosis: indications for treatment.

Authors:  O P Sharma
Journal:  West J Med       Date:  1983-05

Review 2.  [Rapidly progressing renal insufficiency as the primary manifestation of systemic sarcoidosis].

Authors:  B Berner; E Schulz; U Wieneke; M A Reuss-Borst; B Sattler; G A Müller
Journal:  Med Klin (Munich)       Date:  1999-12-15

3.  The indications for the treatment of sarcoidosis: Wells Law.

Authors:  Robert P Baughman; Marc A Judson; Athol Wells
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

4.  Prognosis in sarcoidosis.

Authors:  J T Macfarlane
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-26

5.  Use of discriminant analysis in assessing pulmonary function worsening in patients with sarcoidosis by a panel of inflammatory biomarkers.

Authors:  Gregorino Paone; Alvaro Leone; Sandro Batzella; Vittoria Conti; Francesco Belli; Laura De Marchis; Alice Mannocci; Giovanni Schmid; Claudio Terzano
Journal:  Inflamm Res       Date:  2012-12-23       Impact factor: 4.575

6.  Incidence and baseline characteristics of relapse or exacerbation in patients with pulmonary sarcoidosis in Japan.

Authors:  Okinori Murata; Katsuya Suzuki; Tsutomu Takeuchi; Atsuko Kudo
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-09-30       Impact factor: 0.670

7.  Neutrophils in Bronchoalveolar Lavage Fluid Indicating the Severity and Relapse of Pulmonary Sarcoidosis.

Authors:  Haoshen Feng; Lili Yan; Yabin Zhao; Zhenhua Li; Jian Kang
Journal:  Front Med (Lausanne)       Date:  2022-02-02

Review 8.  Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns.

Authors:  Marc A Judson
Journal:  F1000Res       Date:  2019-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.